Disitamab Vedotin (RC48-ADC) in Breast Cancer
NCT05851677
·
clinicaltrials.gov ↗
RECRUITING
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Disitamab vedotin
Sponsor
RenJi Hospital